Home > Financial Ratios > FREDUN PHARMACEUTICALS

FREDUN PHARMACEUTICALS
EV/Core EBITDA

    Back to All Ratios
FREDUN PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for FREDUN PHARMACEUTICALS
Please provide your vote to see the results

FREDUN PHARMACEUTICALS Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2026Mar2025
   EV/Core EBITDA(x) 11.348.70

What is the latest EV/Core EBITDA ratio of FREDUN PHARMACEUTICALS ?

The latest EV/Core EBITDA ratio of FREDUN PHARMACEUTICALS is 11.34 based on Mar2026 Consolidated results.
Year EV/Core EBITDA
Mar202611.34
Mar20258.70

How is EV/Core EBITDA of FREDUN PHARMACEUTICALS Trending?

Years EV/Core EBITDA % Change
Mar2026 11.34
30.34
Mar2025 8.7 -

Other Financial Ratios of FREDUN PHARMACEUTICALS


Compare EV/Core EBITDA ratio of peers of FREDUN PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
FREDUN PHARMACEUTICALS ₹1,639.8 Cr 7.3% 22.1% 247% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹467,870.0 Cr 0.7% 8.1% 16% Stock Analytics
DIVIS LABORATORIES ₹194,316.0 Cr 7% 10.2% 3.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹169,316.0 Cr 2.5% 11.3% 49.6% Stock Analytics
CIPLA ₹115,477.0 Cr -0.3% 4.1% -3.3% Stock Analytics
DR REDDYS LABORATORIES ₹102,156.0 Cr -3.2% -3.9% -3% Stock Analytics


FREDUN PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
FREDUN PHARMACEUTICALS

7.3%

22.1%

247%

SENSEX

0.6%

1.2%

-7.8%


You may also like the below Video Courses